Anti-EGFR [7D12]

Description:

Recombinant monoclonal antibody to EGFR. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the phage display antibody 7D12.

Clone Name:

7D12

Published Application(s):

Blocking, crystallization, FACS, in vivo, inhibition, SPR, ELISA

Published Species Reactivity:

Monkey, Human

UniProt Accession Number of Target Protein: P00533

Alternative Name(s) of Target: EC:2.7.10.1; Epidermal growth factor receptor; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1
Immunogen: The original antibody was generated by immunizing Llama glama with human epidermal A431 carcinoma cells. After cloning variable domains of the heavy-chain antibodies from the peripheral blood and lymph node lymphocytes, a phage-displayed library was constructed. The antibody was isolated by panning on immobilized EGFRs.

Specificity: The antibody is specific for EGFR. The epitope lies on domain III of the EGFR. The antibody sterically inhibits EGF binding to its receptor.

Application Notes: The binding affinity of the VHH fragment to the EGFR extracellular region was measured by surface plasmon resonance. The crystal structure of the antibody in complex with EGFR was determined (Schmitz et al. 2013; PMID: 23791944). The specificity of the antibody to human EGFRvIII protein and monkey EGFR was confirmed by ELISA analysis. The antibody could bind to the human EGFR protein on the surface of A431 cells and CHO-K1-human EGFR 1D4 cells and monkey EGFR protein on the surface of 293 and HEK293T cells by FACS analysis. The antibody bound to human EGFRvIII protein on the surface of CHO-K1-EGFRvIII1C6 cells by FACS analysis. The binding affinity of the Fab and IgG fragments to VEGFR-2 was measured by surface plasmon resonance (Kd= 4 nM) (WO2022121928A1). The ^99mTc-labeled antibody could block EGFR on A431 cells in in vitro experiments. Mice bearing subcutaneous A431 (EGFR-positive) and R1M (EGFRnegative) xenografts were intravenously injected with the labeled antibody. Image analysis showed high tumor uptake values (4.62 %IA/cm³) in A431 xenografts, whereas the uptake in the negative tumor (R1M) was low (1.49 %IA/cm³). Further, the original antibody showed low liver uptake, and rapid blood clearance (Gainkam et al., 2008; PMID: 18413403). The original format of the antibody could block the binding of EGF to the EGFR and it competed for the binding of cetuximab but not for that of the scFv of matuzumab. The antibody showed low IC50 for EGF binding (8 nM) and low off-rate (2.5 × 10⁻³/s). A bi-paratopic anti-EGFR nanobody 7D12-9G8 was constructed. It showed good inhibition of EGFR signalling. The bi-paratopic 7D12-9G8 molecule could inhibit A431 cell proliferation (Roovers et al., 2011; PMID: 21520037). The original antibody was fused to a human Fc portion (7D12-hcAb). 7D12-hcAb was able to bind and block EGFR with all tested acquired resistance mutations and—if Fc-engineered—may boost ADCC/Fc-mediated effector functions also in EGFR variants with low affinity to conventional EGFR antibodies or downstream on ras sarcoma gene (RAS) mutated clones (Tintelnot et al., 2019; PMID: 30824613).

Antibody first published in: Gainkam et al. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT J Nucl Med. 2008 May;49(5):788-95. doi: 10.2967/jnumed.107.048538. Epub 2008 Apr 15. PMID:18413403
Note on publication: The original paper describes the generation and characterization of the antibody.

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
ASP.NET_SessionId	session	Issued by Microsoft's ASP.NET Application, this cookie stores session data during a user's website visit.
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Cookie	Duration	Description
_dc_gtm_UA-49047364-1	1 minute	No description
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_gcl_au	3 months	Provided by Google Tag Manager to experiment advertisement efficiency of websites using their services.
_gid	1 day	Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
ai_session	30 minutes	This is a unique anonymous session identifier cookie set by Microsoft Application Insights software to gather statistical usage and telemetry data for apps built on the Azure cloud platform.
ai_user	1 year	A unique user identifier cookie, set by Microsoft Application Insights software, that enables counting of the number of users accessing the application over time.

Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

Cookie	Duration	Description
_uetsid	1 day	Bing Ads sets this cookie to engage with a user that has previously visited the website.
_uetvid	1 year 24 days	Bing Ads sets this cookie to engage with a user that has previously visited the website.
MUID	1 year 24 days	Bing sets this cookie to recognize unique web browsers visiting Microsoft sites. This cookie is used for advertising, site analytics, and other operations.
test_cookie	15 minutes	The test_cookie is set by doubleclick.net and is used to determine if the user's browser supports cookies.